Get 20% lifetime commission for referring investors to digrin.com
here.
Global Cord Blood Corporation - stock earnings
CORBF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | 16.0 million USD | 44.4 million USD |
| 2022Q1 | 16.5 million USD | 46.8 million USD |
| 2021Q4 | 21.3 million USD | 49.9 million USD |
| 2021Q3 | 19.5 million USD | 48.7 million USD |
| 2021Q2 | 21.1 million USD | 48.8 million USD |
| 2021Q1 | 19.5 million USD | 46.1 million USD |
| 2020Q4 | 17.8 million USD | 44.5 million USD |
| 2020Q3 | 19.4 million USD | 42.1 million USD |
| 2020Q2 | 18.8 million USD | 39.8 million USD |
| 2020Q1 | 13.7 million USD | 42.2 million USD |
| 2019Q4 | 20.8 million USD | 48.0 million USD |
| 2019Q3 | 16.9 million USD | 44.1 million USD |
| 2019Q2 | 15.8 million USD | 39.8 million USD |
| 2019Q1 | 13.5 million USD | 37.4 million USD |
| 2018Q4 | 8.9 million USD | 37.0 million USD |
| 2018Q3 | 9.5 million USD | 35.9 million USD |
| 2018Q2 | 11.1 million USD | 35.3 million USD |
| 2018Q1 | 4.9 million USD | 37.1 million USD |
| 2017Q4 | 10.7 million USD | 37.6 million USD |
| 2017Q3 | 10.2 million USD | 35.2 million USD |
| 2017Q2 | 10.2 million USD | 33.1 million USD |
| 2017Q1 | 5.5 million USD | 29.4 million USD |
| 2016Q4 | 8.0 million USD | 28.9 million USD |
| 2016Q3 | 2.5 million USD | 27.8 million USD |
| 2016Q2 | 2.4 million USD | 26.1 million USD |
| 2016Q1 | 1.3 million USD | 24.3 million USD |
| 2015Q4 | 7.8 million USD | 26.1 million USD |
| 2015Q3 | 2.9 million USD | 27.0 million USD |
| 2015Q2 | 2.2 million USD | 26.7 million USD |
| 2015Q1 | 2.7 million USD | 26.3 million USD |
| 2014Q4 | 5.4 million USD | 26.9 million USD |
| 2014Q3 | 4.4 million USD | 24.8 million USD |
| 2014Q2 | 4.8 million USD | 24.7 million USD |
| 2014Q1 | 6.4 million USD | 24.5 million USD |
| 2013Q4 | 5.7 million USD | 24.9 million USD |
| 2013Q3 | 4.1 million USD | 23.1 million USD |
| 2013Q2 | 5.4 million USD | 21.0 million USD |
| 2013Q1 | 3.7 million USD | 21.4 million USD |
| 2012Q4 | 5.4 million USD | 23.9 million USD |
| 2012Q3 | 3.9 million USD | 20.4 million USD |
| 2012Q2 | 4.9 million USD | 18.2 million USD |
| 2012Q1 | 4.6 million USD | 15.8 million USD |
| 2011Q4 | 6.3 million USD | 15.0 million USD |
| 2011Q3 | 3.6 million USD | 15.3 million USD |
| 2011Q2 | 6.2 million USD | 13.6 million USD |
| 2011Q1 | 4.0 million USD | 14.5 million USD |
| 2010Q4 | 3.9 million USD | 13.8 million USD |
| 2010Q3 | 3.3 million USD | 12.4 million USD |
| 2010Q2 | 2.6 million USD | 10.5 million USD |
| 2010Q1 | 2.4 million USD | 10.4 million USD |
| 2009Q4 | 3.0 million USD | 10.3 million USD |
| 2009Q3 | 2.6 million USD | 9.4 million USD |
| 2009Q2 | -674426 USD | 8.5 million USD |
| 2009Q1 | -289930 USD | 1.2 million USD |
| 2008Q4 | -1.1 million USD | 1.2 million USD |
| 2008Q3 | -166891 USD | 1.1 million USD |
| 2008Q2 | 42585 USD | 702395 USD |
| 2008Q1 | 38528 USD | 986708 USD |
| 2007Q4 | 113216 USD | 733119 USD |
| 2007Q3 | 96032 USD | 108683 USD |
| 2007Q2 | 63170 USD | 85117 USD |
| 2007Q1 | 113379 USD | ? USD |
CORBF Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 78.9 million USD | 195.8 million USD |
| 2021 | 77.6 million USD | 177.0 million USD |
| 2020 | 66.3 million USD | 172.1 million USD |
| 2019 | 43.3 million USD | 146.6 million USD |
| 2018 | 37.7 million USD | 149.1 million USD |
| 2017 | 18.3 million USD | 110.5 million USD |
| 2016 | 14.1 million USD | 102.7 million USD |
| 2015 | 17.3 million USD | 102.5 million USD |
| 2014 | 21.3 million USD | 92.4 million USD |
| 2013 | 18.1 million USD | 84.8 million USD |
| 2012 | 20.9 million USD | 60.4 million USD |
| 2011 | 14.0 million USD | 51.9 million USD |
| 2010 | 7.2 million USD | 38.4 million USD |
| 2009 | -1.2 million USD | 4.2 million USD |
| 2008 | 409054 USD | 2.0 million USD |
| 2007 | 2344 USD | ? USD |
CORBF
Price: $1.25
52 week price:
Earnings Per Share: 0.57 USD
P/E Ratio: 2.07
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 167.4 million